Abstract
Head and neck (HN) cancer is a significant health-care problem worldwide. One of the major prognostic factors for squamous cell carcinomas of the head and neck (HNSCC) is metastasis. Early detection of lymph node metastasis and the identification of key protein targets for the treatment of metastatic HNSCC remain a challenge in current cancer research. Recent developments in molecular analysis technologies, such as DNA microarray and proteomic analyses, have provided powerful tools for the detection of metastatic signatures in primary tumors, opening new avenues toward the molecular diagnosis and prognosis of HN cancers. Evaluation of gene expression profiling identified in metastatic signatures has further facilitated the understanding of HNSCC metastasis at the molecular level. This review will focus on current exploration of metastatic proteins in HNSCC with an emphasis on molecular signatures of metastatic HNSCC in order to understand the functions of metastasis-related proteins involved in adhesion, invasion, dissemination, and survival, and to define appropriate biomarkers and targets for the treatment of this disease.
Keywords: DNA microarray, chemokine receptors, matrix metalloproteinases, tumors, mitogen-activated protein kinase
Current Cancer Drug Targets
Title: Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer
Volume: 7 Issue: 7
Author(s): Zhuo (Georgia) Chen
Affiliation:
Keywords: DNA microarray, chemokine receptors, matrix metalloproteinases, tumors, mitogen-activated protein kinase
Abstract: Head and neck (HN) cancer is a significant health-care problem worldwide. One of the major prognostic factors for squamous cell carcinomas of the head and neck (HNSCC) is metastasis. Early detection of lymph node metastasis and the identification of key protein targets for the treatment of metastatic HNSCC remain a challenge in current cancer research. Recent developments in molecular analysis technologies, such as DNA microarray and proteomic analyses, have provided powerful tools for the detection of metastatic signatures in primary tumors, opening new avenues toward the molecular diagnosis and prognosis of HN cancers. Evaluation of gene expression profiling identified in metastatic signatures has further facilitated the understanding of HNSCC metastasis at the molecular level. This review will focus on current exploration of metastatic proteins in HNSCC with an emphasis on molecular signatures of metastatic HNSCC in order to understand the functions of metastasis-related proteins involved in adhesion, invasion, dissemination, and survival, and to define appropriate biomarkers and targets for the treatment of this disease.
Export Options
About this article
Cite this article as:
Chen (Georgia) Zhuo, Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer, Current Cancer Drug Targets 2007; 7 (7) . https://dx.doi.org/10.2174/156800907782418301
DOI https://dx.doi.org/10.2174/156800907782418301 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases
Current Pharmaceutical Biotechnology Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives
Current Drug Targets Employing Genetic Markers to Improve Diagnosis of Thyroid Tumor Fine Needle Biopsy
Current Genomics Venous Collateral Circulation of the Extracranial Cerebrospinal Outflow Routes
Current Neurovascular Research Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer
Current Gene Therapy The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
Current Medicinal Chemistry Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
Current Protein & Peptide Science Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening Lymphatic Drainage in Patients with Primary Cutaneous Melanoma - the Role of Lymphoscintigraphy in Sentinel Lymph Node Biopsy
Current Medical Imaging A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options
Current Medicinal Chemistry Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design
Anti-Cancer Agents in Medicinal Chemistry CYLD-Mediated Signaling and Diseases
Current Drug Targets Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
Current Cancer Drug Targets Role of Unani Medicines in Cancer Control and Management
Current Drug Therapy Triggered Activation and Release of Liposomal Prodrugs and Drugs in Cancer Tissue by Secretory Phospholipase A2
Current Drug Delivery Pharmacophore Modeling and 3D QSAR Studies of Novel Human Carbonic Anhydrase IX Inhibitors
Letters in Drug Design & Discovery Biomarkers in Molecularly Targeted Therapy for Cancer
Recent Patents on Biomarkers The Pathophysiological Basis of Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
Current Vascular Pharmacology The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress
Current Molecular Medicine The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer
Current Medicinal Chemistry